O
RDUS

OppenheimerFunds’s Radius Health, Inc. RDUS Stock Holding History

OppenheimerFunds’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-832,850
Closed -$14.8M – 1875
2018
Q3 		$14.8M Sell
832,850
-180
-0% -$4.07K 0.02% 655
2018
Q2 		$24.6M Buy
833,030
+1,000
+0.1% +$31.6K 0.03% 531
2018
Q1 		$29.9M Buy
+832,030
New +$30.1M 0.04% 454
2017
Q2 		– Sell
-301,631
Closed -$11.7M – 1907
2017
Q1 		$11.7M Buy
301,631
+831
+0.3% +$34.9K 0.01% 741
2016
Q4 		$11.4M Hold
300,800
– – 0.01% 733
2016
Q3 		$16.3M Sell
300,800
-57,120
-16% -$2.9M 0.02% 632
2016
Q2 		$13.2M Hold
357,920
– – 0.02% 667
2016
Q1 		$11.3M Buy
+357,920
New +$12.4M 0.01% 702

Other funds holding RDUS

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OppenheimerFunds's RDUS Position: Q4 2018 in Review

OppenheimerFunds sold out of Radius Health, Inc. (RDUS) in Q4 2018, closing a stake of 832,850 shares — an estimated $14.8M sold.

OppenheimerFunds first reported a position in RDUS in Q1 2016 and held it in 8 quarters. The position peaked at $29.9M in Q1 2018. 123 funds tracked by Wall St. Rank hold RDUS as of Q4 2018.

  • OppenheimerFunds reported no remaining Radius Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • OppenheimerFunds sold 832,850 Radius Health, Inc. shares in Q4 2018, an estimated $14.8M.
  • OppenheimerFunds first reported a position in Radius Health, Inc. in Q1 2016 and held it in 8 quarters.
  • OppenheimerFunds's Radius Health, Inc. position peaked at $29.9M in Q1 2018.
  • 123 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q4 2018.

Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.